Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study
- Resource Type
- Article
- Authors
- Hamadani, Mehdi; Collins, Graham P; Caimi, Paolo F; Samaniego, Felipe; Spira, Alexander; Davies, Andrew; Radford, John; Menne, Tobias; Karnad, Anand; Zain, Jasmine M; Fields, Paul; Havenith, Karin; Cruz, Hans G; He, Shui; Boni, Joseph; Feingold, Jay; Wuerthner, Jens; Horwitz, Steven
- Source
- In The Lancet Haematology June 2021 8(6):e433-e445
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2352-3026